Sterol Carrier Protein 2, a Critical Host Factor for Dengue Virus Infection, Alters the Cholesterol Distribution in Mosquito Aag2 Cells

Journal of Medical Entomology

Volumn 52, Issue 5, 2015, Pages 1124-1134

  Fu, Qiang ^a   Inankur, Bahar ^a   Yin, John ^a   Striker, Rob ^b   Lan, Que ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Aedes aegypti; Cholesterol; Dengue; host factor; SCP 2

Indexed keywords

CARRIER PROTEIN; CHOLESTEROL; INSECT PROTEIN; STEROL CARRIER PROTEINS;

AEDES; ANIMAL; CELL LINE; DENGUE; DENGUE VIRUS; DISEASE CARRIER; GENETICS; METABOLISM; PHYSIOLOGY; TRANSMISSION; VIROLOGY;

AEDES; ANIMALS; CARRIER PROTEINS; CELL LINE; CHOLESTEROL; DENGUE; DENGUE VIRUS; INSECT PROTEINS; INSECT VECTORS;

EID: 84944252961     PISSN: 00222585     EISSN: 19382928     Source Type: Journal    
DOI: 10.1093/jme/tjv101     Document Type: Article

References (66)

1. Acosta, E. G., V. Castilla, and E. B. Damonte. 2008. Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis. J. Gen. Virol. 89: 474-484.
2. Aizaki, H., M. Fukasawa, H. Toni, Y.Matsuura, K. Hanada, M. Lai, T. Miyamura, T. Wakita, and T. Suzuki. 2007. The cholesterol and sphingolipids of hepatitis C virus particles play critical roles in the viral infectivity. Hepatology 46: 453A-454A.
3. Atshaves, B. P., S. M. Storey, A. L. McIntosh, A. D. Petrescu, O. I. Lyuksyutova, A. S. Greenberg, and F. Schroeder. 2001. Sterol carrier protein-2 expression modulates protein and lipid composition of lipid droplets. J. Biol. Chem. 276: 25324-25335.
4. Atshaves, B., A. McIntosh, G. Martin, D. Landrock, H. Payne, S. Bhuvanendran, K. Landrock, O. Lyuksyutova, J. Johnson, R. Macfarlane, et al. 2009. Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fedmice. J. Lipid. Res. 50: 1429-1447.
5. Blitzer,E., I. Vyazunova, andQ.Lan.2005. Functional analysis of AeSCP-2 using gene expression knockdown in the yellow fevermosquito, Aedes aegypti. InsectMol. Biol. 14: 301-307.
6. Buckner,E. A., B.W. Alto, and L. P. Lounibos. 2013. Vertical transmission of key west dengue-1 virus by Aedes aegypti and Aedes albopictus (Diptera: Culicidae) mosquitoes from Florida. J. Med. Entomol. 50: 1291-1297.
7. Che, P., L. Wang, and Q. Li. 2009. The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus. Int. J. Clin. Exp. Med. 2: 363-373.
8. Chu, J. J., and M. L. Ng. 2004. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol. 78: 10543-10555.
9. Chu, J., and P. Yang. 2007. c-Src protein kinase inhibitors block assembly and maturation of dengue virus. PNAS 104: 3520-3525.
10. Clayton, R. B. 1964. The utilization of sterols by insects. J. Lipid Res. 5: 3-19.
11. Dyer, D., V.Wessely, K. Forest, and Q. Lan. 2008. Threedimensional structure/function analysis of SCP-2-like2 reveals differences among SCP-2 family members. J. Lipid. Res. 49: 644-653.
12. Endo, A. 1992. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid. Res. 33: 1569-1582.
13. Fallon, A.M., and D. Sun. 2001. Exploration of mosquito immunity using cells in culture. Insect Biochem. Mol. Biol. 31: 263-78.
14. Fernandez-Garcia, M. D., M. Mazzon, M. Jacobs, and A. Amara. 2009. Pathogenesis of flavivirus infections, using and abusing the host cell. CellHostMicrobe. 5: 318-328.
15. Gallegos, A., B. Atshaves, S. Storey, O. Starodub, A. Petrescu, H. Huang, A. McIntosh, G. Martin, H. Chao, A. Kier, et al. 2001. Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog. Lipid. Res. 40: 498-563.
16. Gillespie, L. K., A. Hoenen, G.Morgan, and J.M.Mackenzie. 2010. The Endoplasmic Reticulum Provides the Membrane Platform for Biogenesis of the Flavivirus Replication Complex. J Virol. 84: 10438-10447.
17. Gimpl, G. H. Jr. 2010. Cholesterol Protein Interaction: Methods and Cholesterol Reporter Molecules. Subcell. Biochem. 51: 1-45.
18. Härmälä, A. S., M. I. Pörn, P. Mattjus, and J. P. Slotte. 1994. Cholesterol transport from plasma membranes to intracellular membranes is inhibited by 3 beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. Biochim. Biophys. Acta 1211: 317-325.
19. Hase, T., P. L. Summers, K. H. Eckels, and W. B. Baze. 1987. An electron and immune-electron microscopic study of dengue-2 virus infection of cultured mosquito cells: Maturation events. Arch. Virol. 92: 273-291.
20. Hase, T., P. L. Summers, and K. H. Eckels. 1989. Flavivirus entry into cultured mosquito cells and human peripheral blood monocytes. Arch. Virol. 104: 129-143.
21. Heaton, N. S., and G. Randall. 2010. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8: 422-432.
22. Kim, M., V. Wessely, and Q. Lan. 2005. Identification of mosquito sterol carrier protein-2 inhibitors. J. Lipid Res. 46: 650-657.
23. Krebs, K., and Q. Lan. 2003. Isolation and expression of a sterol carrier protein-2 gene from the yellow fever mosquito, Aedes aegypti. InsectMol. Biol. 12: 51-60.
24. Kriska, T., A. Pilat, J. C. Schmitt, A. W. Girotti. 2010. Sterol carrier protein-2 (SCP-2) involvement in cholesterol hydroperoxide cytotoxicity as revealed by SCP-2 inhibitor effects. J Lipid Res. 51: 3174-3184.
25. Kuhn, R. J., W. Zhang, M. G. Rossmann, S. V. Pletnev, J. Corver,E. Lenches, C. T. Jones, S.Mukhopadhyay, P. R. Chipman, E. G. Strauss, T. S. Baker, and J. H. Strauss. 2002. Structure of Dengue Virus: Implications for Flavivirus Organization,Maturation, and Fusion. Cell. 108: 717-725.
26. Kyle, J., andE. Harris. 2008. Global spread and persistence of dengue. Annu. Rev. Microbiol. 62: 71-92.
27. Lan, Q., and R. Massey. 2004. Subcellular localization of the mosquito sterol carrier protein-2 and sterol carrier protein-x. J. Lipid. Res. 45: 1468-1474.
28. Larson, R.,V.Wessely,Z. Jiang, andQ.Lan.2008. Larvicidal activity of sterol carrier protein-2 inhibitor in four species of mosquitoes. J.Med. Entomol. 45: 439-444.
29. Lee,C., H. Lin,C. Liao, and Y. Lin. 2008. Cholesterol effectively blocks entry of flavivirus. J. Virol. 82: 6470-6480.
30. Lindenbach, B. D., and C. M. Rice. 2003. Molecular biology of flaviviruses. Adv. Virus Res. 59: 23-61.
31. Liscum, L., and J. R. Faust. 1989. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J. Biol. Chem. 264: 11796-11806.
32. Mackenzie, J. M., and E. G. Westaway. 2001. Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol. 10787-10799.
33. Mackenzie, J., A. Khromykh, and R. Parton. 2007. Cholesterol manipulation by West Nile virus perturbs the cellular immune response. CellHostMicrobe. 2: 229-239.
34. Marquardt, M. T., T. Phalen, andM. Kielian. 1993. Cholesterol is required in the exit pathway of Semliki Forest virus. J. Cell. Biol. 123: 57-65.
35. Martinez-Gutierrez, M., J. Castellanos, and J. Gallego-Gomez. 2011. Statins reduce dengue virus production via decreased virion assembly. Intervirology 54: 202-216.
36. Martins, V.E.P., C. H. Alencar,M. T. Kamimura, F.M. de Carvalho Araújo, S.G.De Simone, R. F. Dutra, andM. I. Guedes. 2012 Occurrence of Natural Vertical Transmission of Dengue-2 andDengue-3 Viruses in Aedes aegypti and Aedes albopictus in Fortaleza, Ceará, Brazil. PLoS ONE 7: e41386
37. Medigeshi, G., A. Hirsch, D. Streblow, J. Nikolich-Zugich, and J. Nelson. 2008. West nile virus entry requires cholesterol-rich membrane microdomains and is independent of alpha v beta 3 integrin. J. Virol. 82: 5212-5219.
38. Moncecchi, D., E. Murphy, D. Prows, and F. Schroeder. 1996. Sterol carrier protein-2 expression in mouse L-cell fibroblasts alters cholesterol uptake. Biochim. Biophy. Acta Lipids LipidMetabol. 1302: 110-116.
39. Nishiura, H., andS. Halstead. 2007. Natural history of dengue virus (DENV)-1 andDENV-4 infections: Reanalysis of classic studies. J. Infect. Dis. 195: 1007-1013.
40. Pastorino, B., A. Nougairède, N. Wurtz, E. Gould, and X. de Lamballerie. 2010. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs. Antiviral Res. 87: 281-294.
41. Perera, R., C. Riley, G. Isaac, A. S. Hopf-Jannasch, R. J. Moore, K. W. Weitz, L. Pasa-Tolic, T. O. Metz, J. Adamec, and R. J. Kuhn. 2012. Dengue Virus Infection Perturbs Lipid Homeostasis in Infected Mosquito Cells. PLoS Pathog 8: e1002584.
42. Pena, J., and E. Harris. 2012. Early dengue virus protein synthesis induces extensive rearrangement of the endoplasmic reticulum independent of the UPR and SREBP-2 Pathway. PLoS ONE 7: e38202.
43. Peng, R., V. Maklokova, J. Chandrashekhar, and Q. Lan. 2011. In vivo functional genomic studies of sterol carrier protein-2 gene in the yellow fever mosquito. PLoS ONE 6: e18030.
44. Peng, R.,Q. Fu,H.Hong, T. Schwaegler, andQ. Lan. 2012. THAP and ATF-2 regulated sterol carrier protein-2 promoter activities in the larval midgut of the yellow fever mosquito, Aedes aegypti. PLoS ONE 7: e46948.
45. Phalen, T., and M. Kielian. 1991. Cholesterol is required for infection by Semliki Forest virus. J. Cell Biol. 112: 615-623.
46. Poh, M. K., G. Shui, X. Xie, P. Y. Shi, M. R. Wenk, and F. Gu. 2012. U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res. 93: 191-198.
47. Radek, J. T., D. H. Dyer, andQ. Lan. 2010. Effects of mutations in Aedes aegypti sterol carrier protein-2 on the biological function of the protein. Biochem 49:7532-7541.
48. Rawson, R. 2003. The SREBP pathway-Insights from insigs and insects.Nat. Rev.Mol. Cell Biol. 4: 631-640.
49. Reed, L., and L. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27: 493-497.
50. Rodenhuis-Zybert, I. A., H. M. van der Schaar, J. M. da Silva Voorham, H. van der Ende-Metselaar, H.-Y. Lei, J. Wilschut, and J. M. Smit. 2010. Immature dengue virus: A veiled pathogen? PLoS Pathog. 6: e1000718.
51. Rolls, M. M., M. T. Marquardt, M. Kielian, and C. E. Machamer. 1997. Cholesterol-independent targeting of Golgi membrane proteins in insect cells. Mol. Biol. Cell 8: 2111-2118.
52. Rothwell,C.,A. LeBreton,C.Ng, J. Lim,W. Liu, S. Vasudevan, M. Labow, F. Gu, and L. Gaither. 2009. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389: 8-19.
53. Rudolf, M., and C. A. Curcio. 2009. Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J. Histochem. Cytochem. 57: 731-739.
54. Samsa,M.M., J. A. Mondotte, N. G. Iglesias, I. Assunção-Miranda, G. Barbosa-Lima, A. T. Da Poian, P. T. Bozza, and A. V. Gamarnik. 2009. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 5: e1000632.
55. Sessions, O., N. Barrows, J. Souza-Neto, T. Robinson, C. Hershey, M. Rodgers, J. Ramirez, G. Dimopoulos, P. Yang, J. Pearson, et al. 2009. Discovery of insect and human dengue virus host factors. Nature 458: 1047-1050.
56. Swick, A., A. Baltes, and J. Yin. 2014. Visualizing infection spread: Dual-color fluorescent reporting of virus-host interactions. Biotech. Bioeng. 111: 1200-1209.
57. Tchankouo-Nguetcheu, S., H. Khun, L. Pincet, P. Roux, M. Bahut, M. Huerre, C. Guette, and V. Choumet. 2010. Differential Protein Modulation in Midguts of Aedes aegypti Infected with Chikungunya and Dengue 2 Viruses. PLoS ONE 5: e13149.
58. Umashankar, M., C. Martin, M. Liao, B. Reilly, A. Guo, G. Taylor, and M. Kielian. 2008. Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J. Virol. 82: 9245-9253.
59. Valle, J., S. Chavez-Salinas, F. Medina, and R. del Angel. 2005. Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J. Virol. 79: 4557-4567.
60. Vancini, R., L. D. Kramer, M. Ribeiro, R. Hernandez, D. Brown. 2013. Flavivirus infection from mosquitoes in vitro reveals cell entry at the plasma membrane. Virology 435: 406-414.
61. van der Schaar, H. M., M. J. Rust, C. Chen, H. van der Ende-Metselaar, J.Wilschut, X.Zhuang, and J.M. Smit. 2008. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 4: e1000244.
62. Vasilakis, N., E. R.Deardorff, J. Kenney, S. L. Rossi, K. A. Hanley, and S. C. Weaver. 2009. Mosquitoes put the brake on evolution: Experimental evolution reveals slower mutation accumulation in mosquito cells than vertebrate cells. PLoS Pathog. 5: e1000467
63. Vyazunova, I., V. Wessley, M. Kim, and Q. Lan. 2007. Identification of two sterol carrier protein-2 like genes in the yellow fever mosquito, Aedes aegypti. Insect Mol. Biol. 16: 305-314.
64. Walther, T. C., and R. V. Farese. 2012. Lipid droplets and cellular lipidmetabolism. Annu. Rev. Biochem. 81: 687-714.
65. Walther, T., R. Farese, and R. Kornberg. 2012. Lipid droplets and cellular lipid metabolism. Annu. Rev. Biochem. 81: 687-714.
66. Welsch, S., S. Miller, I. Romero-Brey, A. Merz, C. K. Bleck, P. Walther, S. D. Fuller, C. Antony, J. Krijnse-Locker, and R. Bartenschlager. 2009. Composition and threedimensional architecture of the dengue virus replication and assembly sites. Cell HostMicrobe. 5: 365-375.